Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

We recommend the following alternatives

W IP IHC       H M R
REACTIVITY SENSITIVITY MW (kDa) SOURCE
93 Rabbit

Product Usage Information

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

Eps8 Antibody recognizes endogenous levels of total human Eps8 protein (both p97 long isoform and p68 short isoform).


Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human Eps8 protein. Antibodies are purified by protein A and peptide affinity chromatography.

Epidermal growth factor receptor pathway substrate 8 (Eps8) is an adaptor protein and can be phosphorylated by several receptor tyrosine kinases including EGFR and Src (1,2). Eps8 is composed of an N-terminal PTB domain, followed by an SH3 domain and a C-terminal effector domain. Eps8 controls actin-based motility by capping the barbed end of actin and bundling actin subunits through its C-terminal effector domain (3,4). The C-terminal α hexlical structure of Eps8 interacts directly with actin to exert these capping and bundling functions (5). The actin capping activity requires the release of Eps8 autoinhibitory binding through SH3 domain interaction with an adaptor molecule, such as Abi-1 (6). This SH3 domain of Eps8 also binds to RN-tre to regulate the down stream Rab5-mediated endocytosis pathway (6). Eps8 functions by binding several receptor tyrosine kinases, such as EGFR or FGFR, to enhance receptor mediated mitogenic Rac signaling and Rab5 endocytosis (6,7). The effector region of Eps8 is necessary for this process. By association with Abi-1 and forming the Eps8/Abi-1/Sos-1 complex, Eps8 couples initial growth factor stimulation to actin motility and the Rac activation pathway (8,9). Eps8 has been shown to be important in the cellular function of filopodial protrusions, cell migration, microvilli formation, and focal adhesion (10-13). Research studies have demonstrated that through its involvement in actin related cellular functions, Eps8 plays a role in cancer cell growth, survival, motility, and invasiveness (14-18).


1.  Fazioli, F. et al. (1993) EMBO J 12, 3799-808.

2.  Gallo, R. et al. (1997) Oncogene 15, 1929-36.

3.  Disanza, A. et al. (2004) Nat Cell Biol 6, 1180-8.

4.  Disanza, A. et al. (2006) Nat Cell Biol 8, 1337-47.

5.  Hertzog, M. et al. (2010) PLoS Biol 8, e1000387.

6.  Lanzetti, L. et al. (2000) Nature 408, 374-7.

7.  Auciello, G. et al. (2013) J Cell Sci 126, 613-24.

8.  Scita, G. et al. (1999) Nature 401, 290-3.

9.  Innocenti, M. et al. (2003) J Cell Biol 160, 17-23.

10.  Welsch, T. et al. (2007) Cancer Lett 255, 205-18.

11.  Frittoli, E. et al. (2011) Immunity 35, 388-99.

12.  Zwaenepoel, I. et al. (2012) Mol Biol Cell 23, 1080-94.

13.  Maa, M.C. et al. (2007) J Biol Chem 282, 19399-409.

14.  Xu, M. et al. (2009) Endocrinology 150, 2064-71.

15.  Chen, Y.J. et al. (2008) Mol Cancer Ther 7, 1376-85.

16.  Yap, L.F. et al. (2009) Oncogene 28, 2524-34.

17.  Chen, H. et al. (2010) Cancer Res 70, 9979-90.

18.  Funato, Y. et al. (2004) Cancer Res 64, 5237-44.


Entrez-Gene Id 2059
Swiss-Prot Acc. Q12929


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

12471
Eps8 Antibody